GSK-207674

Study Sponsor: GSK

Study Title

A randomised, double-blind, parallel group study to evaluate the safety, tolerability and pharmacokinetics of a single dose of GSK2269557 administered via the ELLIPTA™ dry powder inhaler to healthy participants

Medicine or Vaccine (generic name)

nemiralisib

Sponsor Identification Number

207674

Trial Registry Identification Number(#'s)

NCT03189589 2017-001073-16

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=207674

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03189589

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2017-001073-16

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. This study is available in CDISC format.

Date Added to this Site

June 2019